Wealth Enhancement Advisory Services LLC Has $53.58 Million Stock Position in Danaher Corporation $DHR

Key Points

• Wealth Enhancement Advisory Services LLC increased its stake in Danaher by 5.5% in Q4 to 226,455 shares, worth about $53.58 million at quarter-end.
• Sell‑side sentiment is positive: 19 analysts rate Danaher a Buy and three a Hold, with an average price target of $253.55 and an overall rating of "Moderate Buy."
• Danaher raised its quarterly dividend to $0.40 (from $0.32), a $1.60 annualized payout (0.8% yield); the ex‑dividend date is March 27 and the dividend is payable April 24.

Wealth Enhancement Advisory Services LLC grew its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 5.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 226,455 shares of the conglomerate's stock after buying an additional 11,900 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Danaher were worth $53,584,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in DHR. Kestra Private Wealth Services LLC increased its position in Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate's stock worth $3,057,000 after purchasing an additional 48 shares in the last quarter. SOL Capital Management CO raised its position in shares of Danaher by 2.8% during the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate's stock worth $363,000 after acquiring an additional 50 shares during the last quarter. Purkiss Capital Advisors LLC lifted its position in shares of Danaher by 3.9% in the 3rd quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate's stock worth $263,000 after purchasing an additional 50 shares during the period. TCTC Holdings LLC boosted its position in Danaher by 0.7% during the third quarter. TCTC Holdings LLC now owns 7,439 shares of the conglomerate's stock valued at $1,475,000 after acquiring an additional 51 shares during the last quarter. Finally, Howard Capital Management Group LLC grew its stake in Danaher by 4.8% during the third quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate's stock worth $230,000 after purchasing an additional 53 shares during the period. Institutional investors own 79.05% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. JPMorgan Chase & Co. increased their target price on Danaher from $270.00 to $275.00 and gave the stock an "overweight" rating in a report on Thursday, January 29th. Morgan Stanley assumed coverage on Danaher in a research report on Monday, December 1st. They set an "overweight" rating and a $270.00 price target for the company. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Danaher in a report on Thursday, January 29th. Robert W. Baird set a $251.00 price objective on Danaher in a research note on Thursday, January 29th. Finally, TD Cowen reiterated a "buy" rating on shares of Danaher in a research note on Wednesday, January 7th. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average price target of $253.55.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.20% of the stock is owned by insiders.

Danaher Stock Down 0.3%

DHR stock opened at $189.46 on Monday. The company's 50 day moving average is $214.33 and its 200 day moving average is $215.04. The stock has a market cap of $133.97 billion, a price-to-earnings ratio of 37.59, a price-to-earnings-growth ratio of 2.57 and a beta of 0.93. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. Danaher's revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the business posted $2.14 earnings per share. Sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. This is a boost from Danaher's previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. Danaher's dividend payout ratio (DPR) is presently 25.40%.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.